EXCELLENT TRANSPLANT OUTCOMES WITH FLUDARABINE-TREOSULFAN (FT) REDUCED-TOXICITY CONDITIONING (RTC) IN COMBINATION WITH DUALT-CELL DEPLETION (TCD) IN MYELOABLATIVE CONDITIONING (MAC)-INELIGIBLE PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS). (May 2023) - Pasic, I.; Remberger, M.; Chen, C.; Gerbitz, A.; Kim, D.; Kumar, R.; Lam, W.; Law, A.; Lipton, J.; Michelis, F.; Novitzky-Basso, I.; Viswabandya, A.; et al.